Department of Emergency Medicine, Johns Hopkins School of Medicine, Baltimore, MD, United States.
Department of Emergency Medicine, Johns Hopkins School of Medicine, Baltimore, MD, United States.
J Crit Care. 2019 Jun;51:111-116. doi: 10.1016/j.jcrc.2019.02.003. Epub 2019 Feb 4.
To determine the risk for acute kidney injury (AKI) attributable to intravenous contrast media (CM) administration in septic patients.
This was a single-center retrospective propensity matched cohort analysis performed in the emergency department (ED) of an academic medical center. All visits for patients ≥18 years who met sepsis diagnostic criteria and had serum creatinine (SCr) measured both on arrival to the ED and again 48 to 72 h later were included. Of 4171 visits, 1464 patients underwent contrast-enhanced CT (CECT), 976 underwent unenhanced CT and 1731 underwent no CT at all.
The primary outcome was incidence of AKI. Logistic regression and between-groups odds ratios with and without propensity-score matching were used to test for an independent association between CM administration and AKI. Incidence of AKI was 7.2%, 9.4% and 9.7% in those who underwent CECT, unenhanced CT and no CT. CM administration was not associated with increased incidence of AKI.
Sepsis is a medical emergency proven to benefit from early diagnosis and rapid initiation of treatment, which is often aided by CECT. Our findings argue against withholding CM for fear of precipitating AKI in potentially septic patients.
确定在脓毒症患者中,静脉注射造影剂(CM)与急性肾损伤(AKI)的相关性风险。
这是一项在学术医疗中心的急诊科进行的单中心回顾性倾向匹配队列分析。所有符合脓毒症诊断标准且在急诊科就诊时及 48-72 小时后两次检测血清肌酐(SCr)的患者均被纳入研究。在 4171 次就诊中,1464 例患者接受了对比增强 CT(CECT)检查,976 例患者接受了非增强 CT 检查,1731 例患者未进行任何 CT 检查。
主要结局为 AKI 的发生率。使用逻辑回归和倾向评分匹配前后的组间比值比来测试 CM 给药与 AKI 之间是否存在独立关联。在接受 CECT、非增强 CT 和未进行 CT 检查的患者中,AKI 的发生率分别为 7.2%、9.4%和 9.7%。CM 给药与 AKI 发生率的增加无关。
脓毒症是一种医学急症,早期诊断和快速开始治疗已被证明有益,而 CECT 常有助于诊断。我们的研究结果表明,不应因担心可能引发 AKI 而在潜在的脓毒症患者中避免使用 CM。